Medical devices, healthcare technology and the business of care
510(k) clearance · K253565

SureSmile Software

Dentsply Sirona, Inc. · Decision date Mar 4, 2026

FDA DECISIONK253565

What did the FDA decide?

FDA records K253565 as a 510(k) premarket notification, with a decision dated Mar 4, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Dental
Decision date
Mar 4, 2026

FDA source record

Regulatory record facts

Identifier
K253565
Regulatory pathway
510(k) premarket notification
Product code
PNN
Decision code
SESE
Decision date
Mar 4, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Orthodontic Software.

Product code
PNN
FDA device class
2

FDA decision timeline

  1. K253565 received

    Application receipt date recorded by FDA.

  2. K253565 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code PNN

Product / regulatory recordCompanyPathwayDecision dateSource
LuxDesignK260421
LuxCreo, Inc.510(k) clearanceOct 23, 2026FDA
InnoDtech, Inc.510(k) clearanceOct 7, 2026FDA
Align Technology, Inc.510(k) clearanceSep 25, 2026FDA
Hangzhou ChohoTech Co., Ltd.510(k) clearanceMay 8, 2026FDA
Amv Consulting, LLC510(k) clearanceJan 7, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Dentsply Sirona, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
York, PA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records